Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis’s Biosimilar Rituxan Is ‘On Track,’ Sandoz Head Says
Novartis’s Biosimilar Rituxan Is ‘On Track,’ Sandoz Head Says
Novartis’s Biosimilar Rituxan Is ‘On Track,’ Sandoz Head Says
Submitted by
admin
on March 7, 2013 - 11:43am
Source:
Bloomberg
News Tags:
Rituxan
biosimilars
Novartis
Sandoz
Headline:
Novartis’s Biosimilar Rituxan Is ‘On Track,’ Sandoz Head Says
Do Not Allow Advertisers to Use My Personal information
